genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.

read more
Latest News:

21.01.2020
3D Genomemedicine Inc is going to operate in USA

read more
  • ++BREAKING NEWS (26.05.2020)++

    Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.

    read more
  • MEDICA 2021

    Visit us at MEDICA in Duesseldorf, Germany:
    15.11. - 18.11.21

    read more
  • Jefferies Virtual London Healthcare Conference

    Visit us at Jefferies Virtual London Healthcare Conference, UK:
    17.11. - 19.11.21

    read more
  • INVEST 2021

    Visit us at INVEST in Stuttgart, Germany:
    23.03. - 24.04.21

    read more
  • LSX Investival Showcase Virtual 2020

    Visit us at Investival Showcase Virtual London, UK:
    11.11. - 16.11.20

    read more

Antibody Conjugate Therapy

Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.

TOP